285 related articles for article (PubMed ID: 31354471)
1. Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
Pan X; Kaminga AC; Wen SW; Wu X; Acheampong K; Liu A
Front Aging Neurosci; 2019; 11():175. PubMed ID: 31354471
[No Abstract] [Full Text] [Related]
2. Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Pan X; Kaminga AC; Jia P; Wen SW; Acheampong K; Liu A
Front Aging Neurosci; 2020; 12():184. PubMed ID: 33024430
[No Abstract] [Full Text] [Related]
3. Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Pan X; Wu X; Kaminga AC; Wen SW; Liu A
Front Aging Neurosci; 2019; 11():61. PubMed ID: 30983988
[No Abstract] [Full Text] [Related]
4. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
5. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
[TBL] [Abstract][Full Text] [Related]
6. Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis.
Liu D; Cao B; Zhao Y; Huang H; McIntyre RS; Rosenblat JD; Zhou H
Neurosci Lett; 2018 Nov; 686():10-16. PubMed ID: 30171911
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of the circulatory, erythrocellular and CSF selenium levels in Alzheimer's disease: A metal meta-analysis (AMMA study-I).
Reddy VS; Bukke S; Dutt N; Rana P; Pandey AK
J Trace Elem Med Biol; 2017 Jul; 42():68-75. PubMed ID: 28595794
[TBL] [Abstract][Full Text] [Related]
8. The 24-hour urinary cortisol in post-traumatic stress disorder: A meta-analysis.
Pan X; Kaminga AC; Wen SW; Wang Z; Wu X; Liu A
PLoS One; 2020; 15(1):e0227560. PubMed ID: 31918435
[TBL] [Abstract][Full Text] [Related]
9. Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.
Xu L; Zhang W; Liu X; Zhang C; Wang P; Zhao X
J Alzheimers Dis; 2018; 62(1):361-372. PubMed ID: 29439342
[TBL] [Abstract][Full Text] [Related]
10. Catecholamines in Post-traumatic Stress Disorder: A Systematic Review and Meta-Analysis.
Pan X; Kaminga AC; Wen SW; Liu A
Front Mol Neurosci; 2018; 11():450. PubMed ID: 30564100
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin and Alzheimer's Disease Risk in the Elderly: a Systematic Review and Meta-Analysis.
Wang Y; Sheng Q; Hou X; Wang B; Zhao W; Yan S; Wang Y; Zhao S
Mol Neurobiol; 2016 Mar; 53(2):1229-1236. PubMed ID: 25609141
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
13. Association of Circulating Apolipoprotein AI Levels in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Tong JH; Gong SQ; Zhang YS; Dong JR; Zhong X; Wei MJ; Liu MY
Front Aging Neurosci; 2022; 14():899175. PubMed ID: 35663584
[TBL] [Abstract][Full Text] [Related]
14. Aluminum Levels in Brain, Serum, and Cerebrospinal Fluid are Higher in Alzheimer's Disease Cases than in Controls: A Series of Meta-Analyses.
Virk SA; Eslick GD
J Alzheimers Dis; 2015; 47(3):629-38. PubMed ID: 26401698
[TBL] [Abstract][Full Text] [Related]
15. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
Kishi T; Matsunaga S; Oya K; Ikuta T; Iwata N
Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091818
[TBL] [Abstract][Full Text] [Related]
16. The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis.
Cheng H; Shang Y; Jiang L; Shi TL; Wang L
Int J Neurosci; 2016; 126(4):299-307. PubMed ID: 26001206
[TBL] [Abstract][Full Text] [Related]
17. Is Periodontal Disease Associated with Alzheimer's Disease? A Systematic Review with Meta-Analysis.
Leira Y; Domínguez C; Seoane J; Seoane-Romero J; Pías-Peleteiro JM; Takkouche B; Blanco J; Aldrey JM
Neuroepidemiology; 2017; 48(1-2):21-31. PubMed ID: 28219071
[TBL] [Abstract][Full Text] [Related]
18. The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.
Shi Y; Gu L; Alsharif AA; Zhang Z
J Alzheimers Dis; 2017; 59(3):1037-1044. PubMed ID: 28731441
[TBL] [Abstract][Full Text] [Related]
19. Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies.
Tang W; Huang Q; Wang Y; Wang ZY; Yao YY
J Neurol Sci; 2014 Oct; 345(1-2):26-36. PubMed ID: 25086857
[TBL] [Abstract][Full Text] [Related]
20. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H
Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
